Eupraxia Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The ESG rating includes 17 UN Sustainable Development Goals including: 'No Poverty', 'Reduced Inequalities' and 'Life on Land'. Alternative companies in the scoring industry group for Eupraxia Pharmaceuticals Inc are displayedin the table. Detailed ESG assessment of Eupraxia Pharmaceuticals Inc can be reached by logging in.
Eupraxia Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 2.7, social score of 6.4 and governance score of 6.7.
5.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 886 | Veracyte Inc | 5.4 | High |
| 886 | Xlife Sciences AG | 5.4 | High |
| 912 | Eupraxia Pharmaceuticals Inc | 5.3 | High |
| 912 | Acer Therapeutics Inc | 5.3 | High |
| 912 | Alembic Pharmaceuticals Ltd | 5.3 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Eupraxia Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Eupraxia Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Eupraxia Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Eupraxia Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Eupraxia Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Eupraxia Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Eupraxia Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. In addition, the company develops product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012.Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.